Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

VEGF signalling causes stalls in brain capillaries and reduces cerebral blood flow in Alzheimer’s mice
Muhammad Ali, Kaja Falkenhain, Brendah N. Njiru, et al.
Brain (2021) Vol. 145, Iss. 4, pp. 1449-1463
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Blood–brain barrier endothelial cells in neurodegenerative diseases: Signals from the “barrier”
Yiwen Yuan, Jian Sun, Qiang Dong, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 40
Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer's disease
MaggiePui Man Hoi, Qian Yue
Neural Regeneration Research (2023)
Open Access | Times Cited: 38
The Role of Oxidative Stress and Inflammation in Obesity and Its Impact on Cognitive Impairments—A Narrative Review
Ruth Naomi, Soo Huat Teoh, Hashim Embong, et al.
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1071-1071
Open Access | Times Cited: 38
Brain‐Penetrating and Disease Site‐Targeting Manganese Dioxide‐Polymer‐Lipid Hybrid Nanoparticles Remodel Microenvironment of Alzheimer's Disease by Regulating Multiple Pathological Pathways
Elliya Park, Lily Yi Li, Chunsheng He, et al.
Advanced Science (2023) Vol. 10, Iss. 12
Open Access | Times Cited: 24
Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer’s disease
Min Zhang, Zhan Zhang, Honghong Li, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Interleukin-22 Contributes to Blood–Brain Barrier Disruption via STAT3/VEGFA Activation in Escherichia coli Meningitis
Ruicheng Yang, Jiaqi Chen, Xinyi Qu, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 3, pp. 988-999
Open Access | Times Cited: 13
Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer’s disease
Hyun‐Sik Yang, Wai‐Ying Wendy Yau, Becky C. Carlyle, et al.
Brain (2024) Vol. 147, Iss. 6, pp. 2158-2168
Closed Access | Times Cited: 10
Interactions between nanoparticles and pathological changes of vascular in Alzheimer’s disease
Ting Lei, Zixiao Yang, Hanmei Li, et al.
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115219-115219
Closed Access | Times Cited: 10
Comprehensive Overview of Alzheimer’s Disease: Etiological Insights and Degradation Strategies
Manish Kumar Singh, Yoonhwa Shin, Songhyun Ju, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6901-6901
Open Access | Times Cited: 9
Homocysteine potentiates amyloid β$$ \upbeta $$‐induced death receptor 4‐ and 5‐mediated cerebral endothelial cell apoptosis, blood brain barrier dysfunction and angiogenic impairment
Ashley M Carey, Rebecca Parodi‐Rullán, Rafael Vázquez‐Torres, et al.
Aging Cell (2024) Vol. 23, Iss. 5
Open Access | Times Cited: 8
Exosomes and non-coding RNAs: bridging the gap in Alzheimer’s pathogenesis and therapeutics
Chunhui Guo, You Yanqiu, Jibing Chen, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Open Access | Times Cited: 1
Loss of endothelial CD2AP causes sex-dependent cerebrovascular dysfunction
Milène Vandal, Ádám Institóris, Louise Reveret, et al.
Neuron (2025)
Closed Access | Times Cited: 1
Towards a better diagnosis and treatment of dementia: Identifying common and distinct neuropathological mechanisms in Alzheimer's and vascular dementia
Alisa Vollhardt, Lutz Froelich, Anna Stockbauer, et al.
Neurobiology of Disease (2025), pp. 106845-106845
Open Access | Times Cited: 1
The VEGFs/VEGFRs system in Alzheimer’s and Parkinson’s diseases: Pathophysiological roles and therapeutic implications
Claudia Ceci, Pedro Miguel Lacal, Maria Luisa Barbaccia, et al.
Pharmacological Research (2024) Vol. 201, pp. 107101-107101
Open Access | Times Cited: 7
Targeting Astrocyte Signaling Alleviates Cerebrovascular and Synaptic Function Deficits in a Diet-Based Mouse Model of Small Cerebral Vessel Disease
Pradoldej Sompol, Jenna L. Gollihue, Blaine E. Weiss, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 10, pp. 1797-1813
Open Access | Times Cited: 13
Cerebrovascular Dysfunction in Alzheimer’s Disease and Transgenic Rodent Models
Xing Fang, Fan Fan, Richard J. Roman
Journal of Experimental Neurology (2024) Vol. 5, Iss. 2, pp. 42-64
Open Access | Times Cited: 5
Pathological angiogenesis was associated with cerebrovascular lesion and neurodegeneration in Alzheimer's disease
Feng Gao, Yaxi Zhan, Qiong Wang, et al.
Alzheimer s & Dementia (2025)
Open Access
The Crucial Role of the Blood–Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications
Sehwan Kim, Un Ju Jung, Sang Ryong Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 386-386
Open Access
Oral prodrug of a novel glutathione surrogate reverses metabolic dysregulation and attenuates neurodegenerative process in APP/PS1 mice
Swetha Pavani Rao, Aminat Omolola Imam-Fulani, Wei Xie, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Neutrophil stalling does not mediate the increase in tau phosphorylation and the cognitive impairment associated with high salt diet
Sung Ji Ahn, Benjamin Goya, Christian Bertomo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
The role of VEGF in Cancer angiogenesis and tumorigenesis: Insights for anti-VEGF therapy
Zhifeng Shi, Mengmeng Kuai, Baohua Li, et al.
Cytokine (2025) Vol. 189, pp. 156908-156908
Closed Access
Carbonic anhydrase inhibitors prevent presymptomatic capillary flow disturbances in a model of cerebral amyloidosis
Eugenio Gutiérrez‐Jiménez, Peter Mondrup Rasmussen, Irene Klærke Mikkelsen, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access
Brain endothelial cells as phagocytes: mechanisms and implications
Rudy Chang, Mark Fisher, Rachita K. Sumbria
Fluids and Barriers of the CNS (2025) Vol. 22, Iss. 1
Open Access
VEGF Paradoxically Reduces Cerebral Blood Flow in Alzheimer’s Disease Mice
Muhammad Ali, Oliver Bracko
Neuroscience Insights (2022) Vol. 17
Open Access | Times Cited: 21
VEGF-A in serum protects against memory impairment in APP/PS1 transgenic mice by blocking neutrophil infiltration
Fangfang Qi, Zejie Zuo, Kaishun Hu, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4374-4389
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top